Impact of COVID-19 pandemic on dermatologists and dermatology practice

Bhat, Yasmeen Jabeen; Aslam, Aaqib; Hassan, Iffat; Dogra, Sunil

doi:10.4103/idoj.idoj_180_20

Cited by 23 publications

(11 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Discussionmentioning

confidence: 99%

“…The large decrease of leprosy cases in China in 2020 might be attributable to changes in the health service during the COVID-19 pandemic, such as interrupted active leprosy surveillance during lockdown and fewer patients presenting to hospital for examination because of the fear of contracting COVID-19. [11][12][13] Although leprosy cases were widely distributed throughout China in recent years, the regional distribution was uneven. In 2020, patients with leprosy were reported in 71.0% provinces (22/31).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiological features of leprosy in China, 2020

Peng¹,

Sun²,

Wang³

et al. 2022

International Journal of Dermatology and Venereology

View full text Add to dashboard Cite

Objective: To describe the epidemiological characteristics of leprosy in China in 2020 and provide a basis for optimizing leprosy prevention and control strategies.Methods: We collected leprosy data from the Leprosy Management Information System in China, which includes data from 31 provinces, autonomous regions, and municipalities, except for Hong Kong, Macao, and Taiwan, and then performed a descriptive analysis of these data.Results: A total of 406 newly detected leprosy cases were reported nationwide in China in 2020, giving an incidence rate of 0.29 per 1,000,000 population. Among the population with leprosy, the proportions of children younger than 15 years, multibacillary cases, and cases with grade 2 disability were 1.2%, 93.3%, and 17.7%, respectively. Southwest China was the region with the largest proportion of new leprosy cases (54.7%). There were 31 relapse leprosy cases reported in 2020. By the end of 2020, there were 1,893 registered leprosy cases reported nationwide, giving a prevalence rate of 1.35 per 1,000,000 population. Conclusion:Leprosy is at a low endemic level in China in terms of the prevalence and incidence rates. However, the geographical distribution of leprosy in China is unbalanced; leprosy is highly endemic in southwest China,

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Epidemiological features of leprosy in China, 2020

Peng¹,

Sun²,

Wang³

et al. 2022

International Journal of Dermatology and Venereology

View full text Add to dashboard Cite

show abstract

“…Prior telephonic appointment gives opportunity to get information about patient demographics and a brief history while booking itself, which reduces the consultation time. [ 13 ] It should be enquired if the child or the attendant has fever, cough, sore throat, difficulty in breathing with or without skin manifestations or any other symptom suggestive of possible COVID infection, in which case, they should be referred to their pediatrician/fever clinic first. Restrict the number of caregivers to 1 parent per child.…”

Section: Recommendations For Pediatric Dermatology Practicementioning

confidence: 99%

“…[ 15 ] Phototherapy should be avoided as chamber can become a source of infection despite sanitizing. [ 13 ] All non-emergency pediatric dermatological procedures (cryosurgery, radiofrequency, electrocautery) should be avoided during this pandemic. For emergency procedures like a skin biopsy, incision and drainage, proper PPE and disinfection should be employed by the operating surgeon and the assistant.…”

Section: Recommendations For Pediatric Dermatology Practicementioning

confidence: 99%

See 1 more Smart Citation

Recommendations for pediatric dermatology practice during COVID-19 pandemic

Gulati

Katakam

Ranugha

et al. 2021

Indian Dermatol Online J

View full text Add to dashboard Cite

The current scenario of the coronavirus disease (COVID-19) pandemic has resulted in a huge disease burden worldwide affecting people across all age groups. Although children get infected by coronavirus, they are less commonly affected. Only 2% of cases are being reported among patients aged less than 20 years of age and childhood cases constitute around 1–5% of them. Moreover, they are less likely to be seriously affected when compared to adults, with more than 90% of them being either asymptomatic or having mild to moderate disease. This could be attributed to less exposure or sensitivity to COVID-19, varying immune response mechanisms, differences in the expression/function of the Angiotensin Converting Enzyme 2 receptors or higher antibody levels to viruses owing to exposures to multiple respiratory infections, protective role of measles and BCG vaccine, and few associated comorbidities. However, children with certain underlying medical conditions like cardiac or respiratory disease, diabetes, immunodeficiency disorders, cancer or on immunosuppressants may be at a higher risk for developing severe disease.

show abstract

International Teledermatology Review

2021

View full text Add to dashboard Cite

Purpose of Review The use of teledermatology has been evolving slowly for the delivery of health care to remote and underserved populations. Improving technology and the recent COVID-19 pandemic have hastened its use internationally. Recent Findings Some barriers to the use of teledermatology have fallen considerably in the last year. Summary Teledermatology use has increased significantly in recent years in both government-sponsored and private health care systems and individual practices. There are no recognized international practice guidelines and variable use within countries. Many barriers remain to increasing the use of teledermatology.

show abstract

Impact of COVID-19 pandemic on dermatologists and dermatology practice

Cited by 23 publications

References 25 publications

Epidemiological features of leprosy in China, 2020

Epidemiological features of leprosy in China, 2020

Recommendations for pediatric dermatology practice during COVID-19 pandemic

International Teledermatology Review

Contact Info

Product

Resources

About